JPRN-UMIN000048360已完成未知
The effects of CGRP pathway monoclonal antibody treatment on inner ear function in patients with migraine: a prospective study - The effects of CGRP pathway monoclonal antibody treatment on inner ear function in patients with migraine: a prospective study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Treatment duration is less than 3 months The patients with migraine with brainstem aura
研究者
相似试验
已完成
不适用
The effect of anti-CGRP antibody treatment on central sensitizatiomigraineJPRN-UMIN000044096Tominaga Hospital200
已完成
不适用
The effect of anti-CGRP antibody treatment on migraine aura symptomsMigraine with auraJPRN-UMIN000044596Tominaga Hospital200
进行中（未招募）
1 期
CAT-Trial: CGRP monoclonal Antibody for Treatment of painful diabetic neuropathy: a double-blind, multicenter, placebo-controlled, international phase II clinical trialCTIS2022-500338-27-00Aarhus University Hospital100
尚未招募
1 期
imotuzumab in COVID-19COVID-19SARS-CoV2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusAcute DiseaseCritical CareRPCEC00000369Center of Molecular Immunology (CIM)40
已完成
不适用
Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients.MigraineNCT05635604Danish Headache Center38